Price Alert: Shares of Aclaris (ACRS) Trade 23.82% Higher at Midday August 5

Equities Staff  |

Today Aclaris Therapeutics Inc (NASDAQ: ACRS) is trading 23.82% up.

The latest price, as of 11:43:47 est, was $17.55. Aclaris has risen $3.43 over the previous day’s close.

110,466 shares exchanged hands.

As of the previous close, Aclaris has a YTD change of 15.34%. The company expects its next earnings on 2022-11-02.

For technical charts, analysis, and more on Aclaris visit the company profile.

About Aclaris Therapeutics Inc

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.

To get more information on Aclaris Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Aclaris Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation

Market Movers

Sponsored Financial Content